Phase 2 preliminary discovers Chinese COVID-19 antibody is sheltered, incites insusceptible reaction: Lancet study Kumar Jeetendra | July 21, 2020 A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has found it is safe and causes an immune reaction, a study published in The Lancet says. Researchers, for example those from the Center for Disease Control and Prevention, said the trial sought to assess the safety and immunogenicity of this vaccine …
WHO chief researcher sees no group invulnerability yet Kumar Jeetendra | July 24, 2020 The chief scientist at the World Health Organization estimates that approximately 50 percent to 60% of the population will have to be resistant to the coronavirus for there to be some protective”herd immunity” effect. Herd immunity is normally achieved through vaccination and occurs when most of a population is immune to a disease, obstructing its …
‘Greatest obstruction’: Where can CanSino test its immunization abroad? Kumar Jeetendra | July 30, 2020 CanSino Biologics Inc, one of several companies globally attempting to create a coronavirus vaccine, should run late-stage trials overseas if it’s to remain in the race, experts say, but it has yet to declare a different country ready to help. Mid-stage trials revealed that its vaccine didn’t work also in people with immunity to a …
Russia to enroll world’s first COVID-19 immunization on August 12 Kumar Jeetendra | August 10, 2020 The Russian COVID-19 vaccine candidate, being jointly developed by the Gamaleya Research Institute along with also the country’s Defence Ministry, is place to get registered on August 12, reports suggest. This would be the primary vaccine candidate against the novel coronavirus to become registered. News reports quoted Russia’s Deputy Health Minister Oleg Gridnev as confirming …
Germany says Russian COVID-19 immunization has not been adequately tried Kumar Jeetendra | August 12, 2020 German Health Minister Jens Spahn on Wednesday stated Russia’s COVID-19 vaccine had not been satisfactorily tested, including the goal would be to have a safe product instead of simply being first to start vaccinating people. President Vladimir Putin declared on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 …
India may get COVID-19 antibody by mid 2021: Bernstein Kumar Jeetendra | August 28, 2020 India is likely to acquire an approved COVID-19 vaccine by the first quarter of 2021, global brokerage firm Bernstein said in a report. “We’re optimistic that there will be an approved vaccine in the marketplace by 1Q calendar year 2021 in India,” the report stated. While the vaccine may be available at USD 3-6 (Rs …
90 Percent of China’s Sinovac Workers, Households took coronavirus vaccine, says CEO Kumar Jeetendra | September 7, 2020 Approximately 90 percent of Sinovac Biotech Ltd employees and their families have obtained an experimental coronavirus vaccine developed by the Chinese company under the nation’s emergency usage programme, its chief executive said on Sunday. The extent of inoculations under the emergency programme, which China launched in July but has released few details about, points to …
WHO says India in converses with join ‘COVAX’ immunization plot Kumar Jeetendra | September 8, 2020 The World Health Organization is in discussions with India about linking the”COVAX” global vaccine allocation program, a senior WHO adviser said on September 7. “India is certainly eligible, like all countries in the world, to be a part of the COVAX centre and talks are continuing in that respect,” Bruce Aylward told a briefing in …
Russia finishes early preliminaries of second potential COVID-19 immunization: Report Kumar Jeetendra | September 8, 2020 Siberia’s Vector virology institute on September 8 finished early-stage human trials, called Phase II, of a second possible Russian vaccine against COVID-19, the state consumer safety watchdog was cited by the Interfax news agency as saying. Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August after finishing early-stage human trials. “Today… …
Russia delivers first group of Sputnik V for open: Report Kumar Jeetendra | September 8, 2020 Russia has released the first batch of COVID-19 vaccine, called Sputnik V, into civil movement and the supplies of the medication to the Russian regions are expected soon, said a report citing Russian Health Ministry. The Russian health ministry enrolled the first vaccine against COVID-19, developed by Gamaleya National Research Center of Epidemiology and Microbiology …
A few immunosuppressants don’t build COVID-19 risk: Scientists Kumar Jeetendra | September 15, 2020 Therapeutics which suppress the immune system in people who have inflammatory diseases like psoriasis and rheumatoid arthritis”are not associated with a significantly greater risk” for contracting COVID-19, according to a study which says these patients should continue taking their medicine as prescribed. Dermatology researchers in the Henry Ford Health System in the US, which treats …
Aurobindo Pharma ties up with BIRAC to create COVID-19 immunization Kumar Jeetendra | September 17, 2020 Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine. Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. “Aurobindo is in the process of preparing a state-of-art manufacturing facility …
